Personalized Immunotherapy via Multiscale Tumor-Immune Modeling and Optimal Control
Abadi Abraha Asgedom, Yohannes Yirga Kefela
This paper develops a multiscale tumor-immune model with optimal control for personalized immunotherapy, achieving 78% tumor reduction in simulations compared to standard-of-care.
bioRxiv · Jun 30, 2026 · PreprintSystems Biology